Dr. Prokop Vodička is a hematologist at the First Department of Internal Medicine of the First Faculty of Medicine, Charles University and the General University Hospital in Prague. He specializes in the diagnosis and treatment of patients with non-Hodgkin lymphomas, particularly diffuse large B-cell lymphoma (DLBCL). His research focuses on real-world data analysis (real-world evidence), development of prognostic indices, and evaluation of the impact of modern therapies in patients with lymphomas. He completed a one-year research fellowship at the Mayo Clinic (2025–2026). Since 2024, he has been a member of the Executive Committee of the Czech Lymphoma Study Group.
